< Back to previous page

Publication

Higher Drug Exposure During the First 24 Weeks of Ustekinumab Treatment Is Associated With Endoscopic Remission in Crohn's Disease

Journal Contribution - Journal Article

Journal: Clinical Gastroenterology and Hepatology

ISSN: 1542-3565

Issue: 3

Volume: 21

Pages: 838 - +

Publication year:2023

WoS Id: 000944836000001
PubMed Id: 34942369
DOI: https://doi.org/10.1016/j.cgh.2021.12.020
Institutional Repository URL: https://lirias.kuleuven.be/3656511

Accessibility:Open